Novavax Inc (NVAX)

37.18
-2.19(-5.56%)
After Hours
37.28
+0.10(+0.27%)
- Real-time Data
  • Volume:
    5,899,696
  • Day's Range:
    36.89 - 39.75
  • 52 wk Range:
    34.88 - 277.80

NVAX Overview

Prev. Close
39.37
Day's Range
36.89-39.75
Revenue
1.29B
Open
39.75
52 wk Range
34.88-277.8
EPS
-19.35
Volume
5,899,696
Market Cap
2.91B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
7,606,270
P/E Ratio
-2.22
Beta
1.51
1-Year Change
-83.22%
Shares Outstanding
78,215,105
Next Earnings Date
03 Nov 2022
What is your sentiment on Novavax?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Novavax Inc Analysis

Novavax Inc Company Profile

Novavax Inc Company Profile

Employees
1541

Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellStrong Sell
  • Hopeless company
    0
    • That created onenof the best.. if not the best COVID vaccines on the market.. + one of the best flu caccines + contributed to the first ever successfull malaria vaccine.. yeah sounds pretty hopless. Thanks for your insight. 😂
      2
  • soon 150 double ur profits
    1
    • 👍🏼😂
      0
  • it's dangerous to short sell now right? What if FDA approval comes in anytime and gap up next day. Then we are screwed?
    0
    • You should short. Countries are loosing the covid measures and not requiring vaccination.
      1
    • FDA approval came through, hope you didn't short sell 💀
      0
  • The bitter end ?
    0
    • I think not yet
      0
  • Positive news pushing up.
    0
    • Should shoot up soon. Its the best vaccine, long shelf life. Just waiting for US approval
      0
      • why do you say that?Have you read article on Novavax Cash secured puts Option on investing.com
        0
      • The vaccines age will end soon…
        0
    • 11% of stocks is shorted
      0
      • god this is going so bad, free falling
        0
        • Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine
          0
          • Hopeless company
            3